Oppenheimer Reiterates Nurix (NRIX) at Outperform, 'see significant upside potential for NRIX'
Tweet Send to a Friend
Oppenheimer analyst Kostas Biliouris reiterated an Outperform rating and $28.00 price target on Nurix (NASDAQ: NRIX).The analyst commented: "We like ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
